- Original Article
-
Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients
-
Xiaoning Wu, Xiaoqian Xu, Jialing Zhou, Yameng Sun, Huiguo Ding, Wen Xie, Guofeng Chen, Anlin Ma, HongXin Piao, Bingqiong Wang, Shuyan Chen, Tongtong Meng, Xiaojuan Ou, Hwai-I Yang, Jidong Jia, Yuanyuan Kong, Hong You
-
Clin Mol Hepatol. 2023;29(3):747-762. Published online May 10, 2023
-
-
View: 1486
Download: 111
- Review
-
Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
-
Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim
-
Clin Mol Hepatol. 2022;28(3):425-472. Published online July 1, 2022
-
-
-
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
-
Seong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, Yuri Cho, Seung Up Kim, Tae Hee Lee, Byoung Kuk Jang, Sang Gyune Kim, Sang Bong Ahn, Haeryoung Kim, Dae Won Jun, Joon-Il Choi, Do Seon Song, Won Kim, Soung Won Jeong, Moon Young Kim, Hong Koh, Sujin Jeong, Jin-Woo Lee, Yong Kyun Cho
-
Clin Mol Hepatol. 2021;27(3):363-401. Published online June 22, 2021
-
-
- Original Article
-
Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion
-
Jihyun An, Kwang Sun Lee, Kang Mo Kim, Do Hyun Park, Sang Soo Lee, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee
-
Clin Mol Hepatol. 2017;23(2):160-169. Published online May 16, 2017
-
-
- Original Article
-
Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B
-
Han Ah Lee, Yeon Seok Seo, Seung Woon Park, Sang Jung Park, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um
-
Clin Mol Hepatol. 2016;22(3):382-389. Published online September 25, 2016
-
-
|